• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Practice Fusion Releases Free EPCS to Ensure I-STOP Compliance for NY Providers

by Jasmine Pennic 03/17/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Practice Fusion

Practice Fusion, a cloud-based EHR for doctors and patients , today announced that it is now certified for the electronic prescribing of controlled substances (EPCS). With this certification, Practice Fusion can help ensure that its New York State physicians are able to comply with the Internet System for Tracking Over-Prescribing Act (I-STOP) requirement for EPCS. Easily accessible from a mobile tablet or device, providers’ can quickly and securely transmit controlled substance prescriptions, further digitizing their office workflow.

With Practice Fusion’s free platform, providers remove the burden of manually writing time-consuming, error-prone, and often stolen paper prescription pads. An industry leader, Practice Fusion is the only cloud-based platform to provide a free, certified EPCS program to the over 77,000 eligible providers in New York State.

Last Friday, New York Gov. Andrew Cuomo signed legislation that would postpone the deadline for doctors in the state of New York to use only electronic prescriptions to March 27, 2016. New York State providers are required to transmit all prescriptions – controlled and non-controlled substances – electronically to pharmacies to help combat overprescribing and doctor-shopping, and to help curtail abuse and illegal diversion of prescriptions without compromising access to controlled substances for legitimate health care purposes. 

With competitor startup costs up to $42,232 to implement an electronic prescribing platform, Practice Fusion removes the financial barrier of adoption by offering providers a cost-effective solution that enables them to be compliant and focus on what they do best, treating patients.  By supporting providers’ compliance with New York State law, Practice Fusion’s robust electronic prescribing platform can aid physicians in improving patient outcomes by helping to reduce the risk of adverse reactions and giving them the necessary tools to help in preventing prescription drug abuse, overdose, fraud, and doctor shopping. “

“By providing EPCS at no cost, we are taking another step to digitize health care and to help provide safer prescriptions for 19 million New York State residents,” said Ryan Howard, Founder and CEO, Practice Fusion.

Related: Guide to Electronic Prescription for Controlled Substances

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: EPCS

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |